The listed company Leap Therapeutics plans to raise $58.88 million through PIPE financing, led by Winklevoss Capital
ChainCatcher news, Nasdaq-listed company Leap Therapeutics announced that it has reached a securities purchase agreement to raise $58,888,888 through a public equity private placement (PIPE), led by Winklevoss Capital. The transaction is expected to be completed on October 8, and the company will use the funds to launch a digital asset treasury.
It is reported that Winklevoss Capital will have the right to nominate two individuals to the Leap board of directors, one of whom will also serve as the chairman of the board.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.






